The Vertical Group
67
23M
34
1.91
6
0.49
19
- Stages of investment
- Areas of investment
Summary
The Vertical Group is the famous VC, which was founded in 1988. The leading representative office of defined VC is situated in the Basking Ridge. The fund was located in North America if to be more exact in United States.
We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Omada Health, TetraLogic Pharmaceuticals, Elron Electronic Industries. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the The Vertical Group, startups are often financed by Warburg Pincus, Maryland Venture Fund, LaunchCapital. The meaningful sponsors for the fund in investment in the same round are Latterell Venture Partners, Domain Associates, U.S. Venture Partners (USVP). In the next rounds fund is usually obtained by Warburg Pincus, U.S. Venture Partners (USVP), The New Markets Growth Fund.
The top activity for fund was in 2006. The higher amount of exits for fund were in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this The Vertical Group works on 2 percentage points less the average amount of lead investments. When the investment is from The Vertical Group the average startup value is 100-500 millions dollars. The fund is constantly included in 2-6 investment rounds annually.
Besides them, we counted 7 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 67
- Lead investments
- 6
- Exits
- 19
- Rounds per year
- 1.91
- Follow on index
- 0.49
- Investments by industry
- Health Care (52)
- Medical Device (39)
- Medical (33)
- Biotechnology (28)
- Therapeutics (14) Show 31 more
- Investments by region
-
- United States (66)
- Israel (1)
- Peak activity year
- 2006
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 235M
- Group Appearance index
- 0.88
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.14
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Luminopia | 27 Jun 2023 | Commercial, Software, Computer Vision, Virtual Reality, Industrial | Early Stage Venture | 16M | United States, Massachusetts, Cambridge |
| OncoMed Pharmaceuticals | 04 Nov 2008 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 154M | United States, California, Redwood City |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.